| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| takalcitol (som takalcitolmonohydrat) 4 mikrogram/gram, kutan salva |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Product containing precisely latanoprost 50 microgram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
2 |
| Product containing precisely ketotifen (as ketotifen fumarate) 250 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release oral drops (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Capsaicin 250 microgram/g cutaneous cream |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely levocabastine (as levocabastine hydrochloride) 500 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Alclometasone dipropionate 500 microgram/g cutaneous cream |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Trifluoperazine (as trifluoperazine hydrochloride) 200 microgram/mL oral solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| takrolimus (som takrolimusmonohydrat) 300 mikrogram/gram, kutan salva |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely desoximetasone 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Terbutaline sulfate 300 microgram/mL oral solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely epinastine hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Tafluprost 15 microgram/mL eye drops |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Emedastine (as emedastine difumarate) 500 microgram/mL eye drops |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Naphazoline hydrochloride 120 microgram/mL eye drops |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Procyclidine hydrochloride 500 microgram/mL oral solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely bimatoprost 300 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 500 microgram/g cutaneous cream |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely becaplermin 100 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 50 microgram/g cutaneous ointment |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| betametasondipropionat 640 mikrogram/gram och klotrimazol 10 milligram/gram, hudkräm |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Ferric ammonium citrate 16 mg/mL and folic acid 100 microgram/mL oral solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| flumazenil 500 mikrogram/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| flumazenil 500 mikrogram/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| atropinsulfat 1 mg/10 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Estradiol 3.125 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| bumetanid 2 mg/4 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| buprenorfin (som buprenorfinhydroklorid) 300 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| buprenorfin (som buprenorfinhydroklorid) 300 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| kalcitriol 1 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| kalcitriol 1 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Dinoprostone 400 microgram/mL vaginal gel |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| kalcitriol 2 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| kalcitriol 2 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Estradiol 1.042 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| fentanyl (som fentanylcitrat) 100 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| fentanyl (som fentanylcitrat) 100 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Estradiol 1.563 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Rotigotine 83.333 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Methadone hydrochloride 400 microgram/mL oral solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| koriogonadotropin alfa 250 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| koriogonadotropin alfa 250 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| klonidinhydroklorid 150 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| klonidinhydroklorid 150 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| karboprost (som karboprosttrometamin) 250 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| karboprost (som karboprosttrometamin) 250 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| dinoproston 750 mikrogram/0,75 ml, infusionsväska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| adrenalin (som adrenalinbitartrat) 1 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Hyoscine 13.889 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| adrenalin (som adrenalinbitartrat) 1 mg/10 ml, injektionsvätska, lösning, spruta |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Testosterone 104.167 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Pholcodine 400 microgram/mL oral solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Buprenorphine 35 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Codeine phosphate 600 microgram/mL oral solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Rotigotine 166.667 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Testosterone 208.333 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| alfakalcidol 1 mikrogram/0,5 ml, injektionsvätska, lösning, ampull |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| alfakalcidol 1 mikrogram/0,5 ml, injektionsvätska, lösning, ampull |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Nicotine 291.667 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |